Heron Therapeutics extends tax benefit preservation plan to 2029
The company amended its shareholder rights plan on August 13, 2026, pushing the expiration date back three years.
Heron Therapeutics, Inc. disclosed in an 8-K that on August 13, 2026, it entered into Amendment No. 1 to its Tax Benefit Preservation Plan, which amends the original plan dated August 14, 2025, between the company and Computershare Trust Company, N.A., acting as rights agent.1
The amendment changes the plan's end date. It revises the definition of "Final Expiration Date" and updates all references to August 14, 2026 in the plan so that they now read August 14, 2029.1
The company noted that the summary in the filing is not a full account of the amendment's terms, directing readers to the actual amendment document, which is attached to the filing as Exhibit 4.1.
Under Item 3.03, the filing states that the rights modification described in Item 1.01 also applies to security holders' rights under that item.
The exhibit list includes the amendment itself, titled "Amendment No. 1 to Tax Benefit Preservation Plan," dated August 13, 2026, between Heron Therapeutics, Inc. and Computershare Trust Company, N.A. as rights agent, along with a cover page interactive data file.
The filing was signed on August 14, 2026, by Ira Duarte, Executive Vice President, Chief Financial Officer.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.